Study design. (A) Overview of the process and principal assumptions of MR. (B) Data sources of the GWASs. (C) Methods performed in the present study.
Abbreviations and Notes: BCC, Blood Cell Consortium; BMA, Bayesian model averaging, a high-throughput method based on non-linear regression; BMI, body mass index; FPG, fasting plasma glucose; FUSION, functional summary-based imputation; GLIDE, Gene-Lifestyle Interactions in Dental Endpoints collaboration consortium; GWAS, genome-wide association study; IVW, inverse variance weighted, the primary method in MR to explore the association between exposure and outcome; LOO, leave-one-out, a method for detecting potential influential SNPs; SNP, single nucleotide polymorphism, as genetic instrumental variables for the exposure and outcome; MACE, model-averaged causal estimate; MIP, marginal probability of inclusion; MR, Mendelian randomization; MR-PRESSO, Mendelian Randomization Pleiotropy RESidual Sum and Outlier, a method for assessing and rectifying pleiotropic SNPs; MSCE, model-specific causal estimate; MVMR, multivariable Mendelian randomization, a MR model for adjusting confounding and mutual correction; Neu, neutrophil; NKT, Natural Killer T cell; pDC, plasmacytoid dendritic cell; PP, posterior probability; TWAS, transcriptome-wide association study; UVMR, univariable Mendelian randomization.